- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.08. | American Academy of Pediatrics publishes its own childhood immunization schedule, further breaking from RFK's revamped ACIP | ||
| 19.08. | Leo posts strong sales growth in US, with more to come from hand eczema drug Anzupgo | ||
| 19.08. | Inhibikase taps commercial chief from Pfizer, Gilead to pave the way for PAH launch | ||
| 19.08. | Bayer brings Aspirina pain relief brand, popular among Hispanic communities, to the US | ||
| 19.08. | Amgen's ChemoCentryx prevails in investor lawsuit centered on autoimmune drug Tavneos | ||
| 19.08. | CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit | ||
| 18.08. | Roche, diagnostic partner tout biomarker-driven bladder cancer win for Tecentriq | ||
| 18.08. | Sarepta shares more Elevidys safety data in response to patient group's FDA petition | ||
| 18.08. | Vanda touts 'landmark' win over FDA in years-long dispute over Hetlioz's jet lag disorder bid | ||
| 18.08. | Novo Nordisk unveils $499 cash-pay Ozempic offering amid continued compounder competition | ||
| 18.08. | Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH | ||
| 15.08. | CDMO OXB raises £60M to support US expansion ambitions | ||
| 15.08. | Lundbeck dials up migraine drug's US peak sales estimate, stays positive on Rexulti's PTSD use | ||
| 15.08. | Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis | ||
| 15.08. | AstraZeneca begins DTC home delivery of self-administered FluMist vaccine | ||
| 15.08. | Precigen scores FDA nod for first-ever treatment for HPV-related disorder | ||
| 14.08. | HHS revives '90s task force designed to improve safety of childhood vaccines | ||
| 14.08. | Eli Lilly endorses Trump's goal of aligning international drug prices | ||
| 14.08. | Enhertu, Keytruda promos put AstraZeneca, Merck at the front of the oncology HCP marketing pack: report | ||
| 14.08. | Trump's drug tariff announcement still 'weeks away': Reuters | ||
| 14.08. | China did not renew approval of controversial Alzheimer's drug, regulator's records show | ||
| 14.08. | Amid tariff-fueled onshoring push, Trump signs order to boost US stockpiling of certain drug ingredients | ||
| 14.08. | Sana Biotechnology drops Washington plant build-out, pivots to CDMOs instead | ||
| 13.08. | CSL's Venofer finally faces generic competition as FDA clears copycats from Viatris, Sandoz and Amphastar | ||
| 13.08. | Exact's Genomic Health puts rival Agendia in ad watchdog's crosshairs over LinkedIn posts |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .